Concord Medical Services
6 hedge funds and large institutions have $921K invested in Concord Medical Services in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 4 closing their positions.
0.04% less ownership
Funds ownership: 0.09% → 0.05% (-0.04%)
40% less funds holding
Funds holding: 10 → 6 (-4)
45% less capital invested
Capital invested by funds: $1.69M → $921K (-$764K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PGCM
Prescott Group Capital Management
Tulsa,
Oklahoma
|
-$739K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$44K |
| 3 |
WS
Wedbush Securities
Los Angeles,
California
|
-$26.7K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$15K |
| 5 |
Renaissance Technologies
New York
|
-$8.13K |
CCM Hedge Fund Activity: Q3 2019 in Review
6 of the 4,573 institutional investors tracked by Wall St. Rank reported a position in Concord Medical Services (CCM) for Q3 2019, worth a combined $921K — down 45% from $1.69M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CCM and 0 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 0 added.
The largest seller was Prescott Group Capital Management, exiting entirely with an estimated $739K sold.
- 6 institutional investors held Concord Medical Services (CCM) as of Q3 2019, down from 10 in Q2 2019.
- Funds reported $921K of Concord Medical Services stock for Q3 2019, down 45% quarter-over-quarter.
- 0 funds opened new Concord Medical Services positions in Q3 2019 and 4 closed out, a net change of -4 holders.
- The largest Concord Medical Services seller in Q3 2019 was Prescott Group Capital Management, an estimated $739K sold.
Based on aggregated 13F filings for Q3 2019.